By Associate Professor Sze-Yuan Ooi

Journal articles

Bulluck H; Paradies V; Barbato E; Baumbach A; Bøtker HE; Capodanno D; De Caterina R; Cavallini C; Davidson SM; Feldman DN; Ferdinandy P; Gili S; Gyöngyösi M; Kunadian V; Ooi SY; Madonna R; Marber M; Mehran R; Ndrepepa G; Perrino C; Schüpke S; Silvain J; Sluijter JPG; Tarantini G; Toth GG; Van Laake LW; Von Birgelen C; Zeitouni M; Jaffe AS; Thygesen K; Hausenloy DJ, 2021, 'Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: A Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)', European Heart Journal, 42, pp. 2630 - 2642, http://dx.doi.org/10.1093/eurheartj/ehab271

Indraratna P; Biswas U; Yu J; Schreier G; Ooi SY; Lovell NH; Redmond SJ, 2021, 'Trials and Tribulations: mHealth Clinical Trials in the COVID-19 Pandemic', Yearbook of Medical Informatics, 30, pp. 272 - 279, http://dx.doi.org/10.1055/s-0041-1726487

Ji N; Xiang T; Bonato P; Lovell NH; Ooi SY; Clifton DA; Akay M; Ding XR; Yan BP; Mok V; Fotiadis DI; Zhang YT, 2021, 'Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients during the COVID-19 Pandemic', IEEE Journal of Biomedical and Health Informatics, 25, pp. 903 - 908, http://dx.doi.org/10.1109/JBHI.2021.3059883

Silvain J; Zeitouni M; Paradies V; Zheng HL; Ndrepepa G; Cavallini C; Feldman DN; Sharma SK; Mehilli J; Gili S; Barbato E; Tarantini G; Ooi SY; Von Birgelen C; Jaffe AS; Thygesen K; Montalescot G; Bulluck H; Hausenloy DJ, 2021, 'Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: A pooled analysis of patient-level data', European Heart Journal, 42, pp. 323 - 334, http://dx.doi.org/10.1093/eurheartj/ehaa885

Lewis J; Li J; Ng B; Ooi S, 2021, 'BetaBlockade and the Reversal of Pacing-induced Cardiomyopathy (PICM) in Functional AV Block', Heart, Lung and Circulation, 30, pp. S151 - S152, http://dx.doi.org/10.1016/j.hlc.2021.06.134

Indraratna P; Biswas U; Liu H; Lovell N; Ooi S, 2021, 'Process Evaluation of the TeleClinical Care Randomised Controlled Trial', Heart Lung and Circulation, 30, pp. s290, http://dx.doi.org/10.1016/j.hlc.2021.06.436

Liou K; Ooi SY, 2020, 'Resting Full-Cycle Ratio (RFR) in the Assessment of Left Main Coronary Disease: Caution Required', Heart Lung and Circulation, 29, pp. 1256 - 1259, http://dx.doi.org/10.1016/j.hlc.2019.12.014

Indraratna P; Tardo D; Yu J; Delbaere K; Brodie M; Lovell N; Ooi SY, 2020, 'Mobile phone technologies in the management of ischemic heart disease, heart failure, and hypertension: systematic review and meta-analysis', Jmir Mhealth and Uhealth, 8, pp. e16695, http://dx.doi.org/10.2196/16695

Gray R; Ooi S; Indraratna P; Wolfenden H, 2020, '078 Apical Myomectomy for Management of Heart Failure With Preserved Ejection Fraction in the Context of Apical Hypertrophic Cardiomyopathy', Heart, Lung and Circulation, 29, pp. S72 - S72, http://dx.doi.org/10.1016/j.hlc.2020.09.085

Lal R; Cabanag M; Dominguez L; Ooi S; Beier S, 2020, '627 Towards Preoperative PCI Procedure Planning With Virtual Reality', Heart Lung and Circulation, 29, pp. s319 - s320, http://dx.doi.org/10.1016/j.hlc.2020.09.634

Liou KP; Ooi SYM; Hoole SP; West NEJ, 2019, 'Fractional flow reserve in acute coronary syndrome: A meta-analysis and systematic review', Open Heart, 6, http://dx.doi.org/10.1136/openhrt-2018-000934

Ooi SY; Ng B; Singarayar S; Hellestrand K; Illes P; Mohamed U; Razak S; Weerasooriya R, 2018, 'BioMonitor 2 Pilot Study: Early Experience With Implantation of the Biotronik BioMonitor 2 Implantable Cardiac Monitor', Heart Lung and Circulation, 27, pp. 1462 - 1466, http://dx.doi.org/10.1016/j.hlc.2017.09.005

Guiney L; Liou K; Li J; Thomas S; Glaros E; Ooi S, 2018, 'Acute Activation of Polymorphonuclear Granulocyte During Percutaneous Coronary Intervention: Comparison of Myeloperoxidase and Elastase Release and Elimination Kinetics', Heart, Lung and Circulation, 27, pp. S434 - S434, http://dx.doi.org/10.1016/j.hlc.2018.06.882

Liou K; Li J; Guiney L; Thomas S; Glaros E; Ooi S, 2018, 'Coronary Myeloperoxidase Provides Superior Characterisation of Coronary Inflammation in Patients Undergoing Percutaneous Coronary Interventions in the Setting of Non-ST Elevation Acute Coronary Syndrome', Heart, Lung and Circulation, 27, pp. S311 - S311, http://dx.doi.org/10.1016/j.hlc.2018.06.598

Del Rosario M; Lovell NH; Fildes J; Holgate K; Yu J; Ferry C; Schreier G; Ooi SY; Redmond S, 2017, 'Evaluation of an mHealth-based Adjunct to Outpatient Cardiac Rehabilitation', IEEE Journal of Biomedical and Health Informatics, http://dx.doi.org/10.1109/JBHI.2017.2782209

Liou K; Keech A; Yu J; Fildes J; Ooi SY, 2017, 'Reply: High Intensity Interval versus Moderate Intensity Continuous Training in Patients with Coronary Artery Disease', Heart Lung and Circulation, 26, pp. 528 - 529, http://dx.doi.org/10.1016/j.hlc.2017.01.006

Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW, 2017, 'Sex Differences in the Clinical Impact of High Platelet Reactivity after Percutaneous Coronary Intervention with Drug-Eluting Stents', Circulation Cardiovascular Interventions, 10, http://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.003577

Liou K; Jepson N; Cao C; Luo R; Pala S; Ooi SY, 2016, 'Drug-eluting Balloon Versus Second Generation Drug Eluting Stents in the Treatment of In-stent Restenosis: A Systematic Review and Meta-analysis', Heart Lung and Circulation, 25, pp. 1184 - 1194, http://dx.doi.org/10.1016/j.hlc.2016.04.001

Nagaraja V; Ooi SY; Nolan J; Large A; De Belder M; Ludman P; Bagur R; Curzen N; Matsukage T; Yoshimachi F; Kwok CS; Berry C; Mamas MA, 2016, 'Impact of incomplete percutaneous revascularization in patients with multivessel coronary artery disease: A systematic review and meta-analysis', Journal of the American Heart Association, 5, http://dx.doi.org/10.1161/JAHA.116.004598

Liou K; Negishi K; Ho S; Russell EA; Cranney G; Ooi SY, 2016, 'Detection of Obstructive Coronary Artery Disease Using Peak Systolic Global Longitudinal Strain Derived by Two-Dimensional Speckle-Tracking: A Systematic Review and Meta-Analysis', Journal of the American Society of Echocardiography, 29, pp. 724 - 735.e4, http://dx.doi.org/10.1016/j.echo.2016.03.002

Robaei D; Back L; Ooi SY; Pitney M; Jepson N, 2016, 'Twelve-month outcomes with a bioresorbable everolimus-eluting scaffold: Results of the ESHC-BVS registry at two Australian centers', Journal of Invasive Cardiology, 28, pp. 316 - 322

Ng B; Singarayar S; Hellestrand K; Illies P; Mohamed U; Razak S; Weerasooriya R; Ooi S-Y, 2016, '96-74: BioMonitor 2 Pilot Study: Subcutaneous Electrocardiograms Transmitted by Home Monitoring', EP Europace, 18, pp. i80 - i80, http://dx.doi.org/10.1093/europace/18.suppl_1.i80a

Ng B; Singarayar S; Hellestrand K; Illies P; Mohamed U; Razak S; Weerasooriya R; Ooi S-Y, 2016, '97-01: BioMonitor 2 Pilot Study: First experience with the Biotronik BioMonitor 2 implantable cardiac monitor', EP Europace, 18, pp. i171 - i171, http://dx.doi.org/10.1093/europace/18.suppl_1.i171c

Liou K; Jepson N; Buckley N; Chen V; Thomas S; Russell EA; Ooi SY, 2016, 'Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial', Cardiovascular Drugs and Therapy, 30, pp. 169 - 175, http://dx.doi.org/10.1007/s10557-016-6641-x

Wickremaarachchi C; Olinga J; Ooi SY; Cranney G, 2016, 'Complete angiographic resolution of cocaine induced coronary artery dissection within eight days without coronary stenting - A case report', Heart Lung and Circulation, 25, pp. e24 - e28, http://dx.doi.org/10.1016/j.hlc.2015.06.829

Liou K; Ho S; Fildes J; Ooi SY, 2016, 'High Intensity Interval versus Moderate Intensity Continuous Training in Patients with Coronary Artery Disease: A Meta-analysis of Physiological and Clinical Parameters', Heart Lung and Circulation, 25, pp. 166 - 174, http://dx.doi.org/10.1016/j.hlc.2015.06.828

Liou K; Ooi S; Jepson N, 2016, 'Bifurcation Percutaneous Coronary Intervention With Bio-resorbable Scaffold: Pushing the Boundary', Heart, Lung and Circulation, 25, pp. S166 - S167, http://dx.doi.org/10.1016/j.hlc.2016.06.391

Liou K; Cranney G; Ooi S; Allan R, 2016, 'Percutaneous Closure of PFO for Secondary Prevention of Paradoxical Embolism Improves Migraine Headaches', Heart Lung and Circulation, 25, pp. s186, http://dx.doi.org/10.1016/j.hlc.2016.06.436

Liou K; Allan M; Ng B; Isbister J; Kellar P; Jepson N; Ooi S, 2016, 'Percutaneous Coronary Intervention in the Very Elderly Patients (>0): Comparison of Efficacy and Safety Outcomes with the Younger Cohort', Heart, Lung and Circulation, 25, pp. S187 - S187, http://dx.doi.org/10.1016/j.hlc.2016.06.438

Liou K; Nagaraja V; Jepson N; Ooi SY, 2015, 'Optimal duration of dual antiplatelet therapy following drug-eluting stents implantation: A meta-analysis of 7 randomised controlled trials', International Journal of Cardiology, 201, pp. 578 - 580, http://dx.doi.org/10.1016/j.ijcard.2015.03.073

Liou K; Ng B; Isbister J; Kellar P; Jepson N; Pitney M; Ooi SY, 2015, 'Peri-procedural myocardial infarction following percutaneous coronary intervention as defined by the Universal Definition predicts increased mortality at 2 years', International Journal of Cardiology, 199, pp. 96 - 98, http://dx.doi.org/10.1016/j.ijcard.2015.07.023

Robaei D; Back LM; Ooi SYM; Pitney MR; Jepson N, 2015, 'Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres', Heart Lung and Circulation, 24, pp. 854 - 859, http://dx.doi.org/10.1016/j.hlc.2015.02.011

Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY, 2015, 'Prognostic significance of peri-procedural myocardial infarction in the era of high sensitivity Troponin: A validation of the joint ACCF/AHA/ESC/WHF Universal definition of type 4a myocardial infarction with high sensitivity Troponin T', Heart Lung and Circulation, 24, pp. 673 - 681, http://dx.doi.org/10.1016/j.hlc.2015.01.007

Liou K; Ho S; Ooi SY, 2015, 'Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis', Annals of Clinical Biochemistry, 52, pp. 370 - 381, http://dx.doi.org/10.1177/0004563214553277

Robaei D; Ford T; Ooi SY, 2015, 'Ankyrin-B Syndrome: A Case of Sinus Node Dysfunction, Atrial Fibrillation and Prolonged QT in a Young Adult', Heart Lung and Circulation, 24, pp. e31 - e34, http://dx.doi.org/10.1016/j.hlc.2014.09.013

Robaei D; Back L; Atique S; Tan R; Ooi S; Giles R; Farshid A; Pitney M; Jepson N, 2015, 'Australian multi-centre experience with bioresorbable vascular scaffolds in “real-world” coronary disease - twelve-month outcomes', Heart Lung and Circulation, 24, pp. s263, http://dx.doi.org/10.1016/j.hlc.2015.06.358

Liou K; Ho S; Ooi S, 2015, 'Comparison of aerobic interval training and moderate continuous training in patients with coronary artery disease', Heart, Lung and Circulation, 24, pp. S453 - S453, http://dx.doi.org/10.1016/j.hlc.2015.06.789

Liou K; Jepson N; Ooi S, 2015, 'Drug-eluting balloon versus second generation drug eluting stents in the treatment of in-stent restenosis: a systematic review and meta-analysis', Heart, Lung and Circulation, 24, pp. S273 - S273, http://dx.doi.org/10.1016/j.hlc.2015.06.381

Robaei D; Back L; Ooi S; Giles R; Pitney M; Jepson N, 2015, 'Long-term safety of an Everolimus-eluting bioresorbable scaffold: two year clinical outcomes in a wide spectrum of coronary lesions', Heart Lung and Circulation, 24, pp. s281, http://dx.doi.org/10.1016/j.hlc.2015.06.398

Nagaraja V; Liou K; Jepson N; Eslick G; Ooi S, 2015, 'Prolonged infusion of bivalirudin improves outcomes in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomised trials', Heart, Lung and Circulation, 24, pp. S295 - S295, http://dx.doi.org/10.1016/j.hlc.2015.06.430

Vickers D; Robaei D; Carlyle A; Lau A; Giles R; Ooi S; Pitney M; Jepson N, 2015, 'Routine debulking rotational atherectomy preparation before drug eluting balloons for the management of in-stent restenosis', Heart Lung and Circulation, 24, pp. s300, http://dx.doi.org/10.1016/j.hlc.2015.06.441

Liou K; Kellar P; Isbister J; Pitney M; Jepson N; Giles R; Friedman D; Lau A; Allan R; Ooi S-Y, 2014, 'PM193 Defining peri-procedural myocardial injury following percutaneous coronary intervention using high-sensitive troponin T assay', Global Heart, 9, pp. e102, http://dx.doi.org/10.1016/j.gheart.2014.03.1580

Nguyen MC; Jepson N; Chia P; Pitney M; Whelan A; Back L; Hendriks R; Ooi S-Y; Kanna R; Ahmadi A, 2014, 'PM200 Australian Experience with AbsorbTM Bioresorbable Scaffold Technology in "Real-World" Coronary Disease', Global Heart, 9, pp. e104, http://dx.doi.org/10.1016/j.gheart.2014.03.1587

May AN; Carlyle A; Pitney M; Ooi SY; Jepson N, 2014, 'PT187 Bioresorbable scaffolds in the treatment of chronic total occlusions (CTO)', Global Heart, 9, pp. e204, http://dx.doi.org/10.1016/j.gheart.2014.03.1957

Arnott C; Pitney M; Ooi S; Jepson N, 2013, 'Early Australian Experience With AbsorbTM Bioresorbable Scaffold Technology in “Real-World” Coronary Disease', Heart Lung and Circulation, 22, pp. s38, http://dx.doi.org/10.1016/j.hlc.2013.05.090

Jepson N; Arnott C; Back L; Ooi S-Y; Pitney M, 2013, 'TCT-425 Real-World Experience with Absorb(tm) Bioresorbable Scaffold Technology - Early Australian Registry Results', Journal of the American College of Cardiology, 62, pp. b131 - b132, http://dx.doi.org/10.1016/j.jacc.2013.08.1166

Pitney M; Jepson N; Giles R; Ooi S; Allan R; Lau A; Friedman D; Loh E; Matthews J; Goldsmith R; Stevenson D, 2012, '30 Day and Twelve Month Outcome Data from Two Combined Public/private Catheter Labs', Heart Lung and Circulation, 21, pp. s143, http://dx.doi.org/10.1016/j.hlc.2012.05.361

Ooi S; Ball S, 2009, 'ACE inhibitors: their propertiesand current role in hypertension', Prescriber, 20, pp. 15 - 28, http://dx.doi.org/10.1002/psb.538

Foo H; Ooi SY; Giles R; Jones P, 2009, 'Scedosporium apiospermum pacemaker endocarditis', International Journal of Cardiology, 131, pp. e81 - e82, http://dx.doi.org/10.1016/j.ijcard.2007.07.056

Liou K; Ooi S-Y; Cranney G; Allan R, 2009, 'Percutaneous closure of patent foramen ovale: A single centre experience', Heart, Lung and Circulation, 18, pp. S222 - S223, http://dx.doi.org/10.1016/j.hlc.2009.05.550

Back to profile page